235 related articles for article (PubMed ID: 10609270)
1. [Hepatocellular carcinoma].
Lemoine A; Azoulay D; Jezequel-Cuer M; Debuire B
Pathol Biol (Paris); 1999 Nov; 47(9):903-10. PubMed ID: 10609270
[TBL] [Abstract][Full Text] [Related]
2. [Screening for hepatocellular carcinoma].
Leone N; Rizzetto M
Minerva Med; 2005 Apr; 96(2):95-108. PubMed ID: 16172579
[TBL] [Abstract][Full Text] [Related]
3. [Biological markers of hepatocellular carcinoma].
Arfaoui D; Elloumi H; Ajmi S
Tunis Med; 2004 Apr; 82(4):329-34. PubMed ID: 15453027
[TBL] [Abstract][Full Text] [Related]
4. Markers for hepatocellular carcinoma.
Wu AH; Sell S
Immunol Ser; 1990; 53():403-22. PubMed ID: 1713067
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathologic features and risk factors for hepatocellular carcinoma: results from a single center in southern Turkey.
Ozer B; Serin E; Yilmaz U; Gümürdülü Y; Saygili OB; Kayaselçuk F; Boyacioğlu S
Turk J Gastroenterol; 2003 Jun; 14(2):85-90. PubMed ID: 14614632
[TBL] [Abstract][Full Text] [Related]
6. Proteomics in the diagnosis of hepatocellular carcinoma: focus on high risk hepatitis B and C patients.
El-Aneed A; Banoub J
Anticancer Res; 2006; 26(5A):3293-300. PubMed ID: 17094443
[TBL] [Abstract][Full Text] [Related]
7. Screening for hepatocellular carcinoma in high-risk individuals. A clinical review.
Regan LS
Arch Intern Med; 1989 Aug; 149(8):1741-4. PubMed ID: 2475078
[TBL] [Abstract][Full Text] [Related]
8. [Echographic detection of hepatocellular carcinoma in patients hospitalized for cirrhosis].
Roget L; Coppéré H; Richard P; Barthélém C; Veyret C; Audigier JC
Gastroenterol Clin Biol; 1988 Nov; 12(11):827-32. PubMed ID: 2464520
[TBL] [Abstract][Full Text] [Related]
9. Alpha-fetoprotein as a tumor marker in hepatocellular carcinoma: investigations in south Indian subjects with hepatotropic virus and aflatoxin etiologies.
Murugavel KG; Mathews S; Jayanthi V; Shankar EM; Hari R; Surendran R; Vengatesan A; Raghuram K; Rajasambandam P; Murali A; Srinivas U; Palaniswamy KR; Pugazhendhi T; Thyagarajan SP
Int J Infect Dis; 2008 Nov; 12(6):e71-6. PubMed ID: 18658001
[TBL] [Abstract][Full Text] [Related]
10. Des-gamma-carboxyprothrombin, alpha-fetoprotein and AFP-L3 in patients with chronic hepatitis, cirrhosis and hepatocellular carcinoma.
Durazo FA; Blatt LM; Corey WG; Lin JH; Han S; Saab S; Busuttil RW; Tong MJ
J Gastroenterol Hepatol; 2008 Oct; 23(10):1541-8. PubMed ID: 18422961
[TBL] [Abstract][Full Text] [Related]
11. [Hepatocellular carcinoma].
Propst A; Propst T; Waldenberger P; Judmaier G; Vogel W
Schweiz Med Wochenschr; 1995 Nov; 125(44):2137-42. PubMed ID: 7502013
[TBL] [Abstract][Full Text] [Related]
12. Clinical and pathological factors associated with the development of hepatocellular carcinoma in patients with hepatitis virus-related cirrhosis: a long-term follow-up study.
Rodríguez-Díaz JL; Rosas-Camargo V; Vega-Vega O; Morales-Espinosa D; Mendez-Reguera A; Martínez-Tlahuel JL; Gamboa-Domínguez A; Arrieta O
Clin Oncol (R Coll Radiol); 2007 Apr; 19(3):197-203. PubMed ID: 17359907
[TBL] [Abstract][Full Text] [Related]
13. Early detection of hepatocellular carcinoma in patients with cirrhosis by alphafetoprotein, ultrasound and fine-needle biopsy.
Tremolda F; Benevegnù L; Drago C; Casarin C; Cechetto A; Realdi G; Ruol A
Hepatogastroenterology; 1989 Dec; 36(6):519-21. PubMed ID: 2482242
[TBL] [Abstract][Full Text] [Related]
14. Prospective study of alpha-fetoprotein in cirrhotic patients monitored for development of hepatocellular carcinoma.
Oka H; Tamori A; Kuroki T; Kobayashi K; Yamamoto S
Hepatology; 1994 Jan; 19(1):61-6. PubMed ID: 7506227
[TBL] [Abstract][Full Text] [Related]
15. Early detection of hepatocellular carcinoma associated with cirrhosis by ultrasound and alfafetoprotein: a prospective study.
Cottone M; Turri M; Caltagirone M; Maringhini A; Sciarrino E; Virdone R; Fusco G; Orlando A; Marino L; Pagliaro L
Hepatogastroenterology; 1988 Jun; 35(3):101-3. PubMed ID: 2456973
[TBL] [Abstract][Full Text] [Related]
16. Impact of occult hepatitis B virus infection and prior hepatitis B virus infection on development of hepatocellular carcinoma in patients with liver cirrhosis due to hepatitis C virus.
Adachi S; Shibuya A; Miura Y; Takeuchi A; Nakazawa T; Saigenji K
Scand J Gastroenterol; 2008; 43(7):849-56. PubMed ID: 18584524
[TBL] [Abstract][Full Text] [Related]
17. Screening for hepatocellular carcinoma. Review and perspective.
Ellis JC
West J Med; 1988 Aug; 149(2):183-7. PubMed ID: 2470205
[TBL] [Abstract][Full Text] [Related]
18. [High risk group for development of hepatocellular carcinoma].
Koike Y; Shiratori Y
Nihon Rinsho; 2001 Oct; 59 Suppl 6():362-6. PubMed ID: 11761973
[No Abstract] [Full Text] [Related]
19. Sensitivity of commonly available screening tests in detecting hepatocellular carcinoma in cirrhotic patients undergoing liver transplantation.
Gambarin-Gelwan M; Wolf DC; Shapiro R; Schwartz ME; Min AD
Am J Gastroenterol; 2000 Jun; 95(6):1535-8. PubMed ID: 10894592
[TBL] [Abstract][Full Text] [Related]
20. Hepatocellular carcinoma: status in the era of liver transplantation.
Singhal A; Jabbour N
J Okla State Med Assoc; 2009 Dec; 102(12):355-61. PubMed ID: 20131731
[No Abstract] [Full Text] [Related]
[Next] [New Search]